The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Emergent Biosolutions Inc shares valued at $187,623 were sold by DeGolyer Donald W on Nov 10 ’25. At $10.54 per share, DeGolyer Donald W sold 17,801 shares. The insider’s holdings dropped to 119,858 shares worth approximately $1.24 million following the completion of this transaction.
Also, Dayal Sujata Tyagi sold 8,552 shares, netting a total of over 85,520 in proceeds. Following the sale of shares at $10.00 each, the insider now holds 88,980 shares.
Before that, DONALD DEGOLYER had added 17,801 shares to its account. In a trade valued at $187,544, the Director bought Emergent Biosolutions Inc shares for $10.54 each.
As published in their initiating research note from H.C. Wainwright on December 30, 2024, Emergent Biosolutions Inc [EBS] has been a Buy and the price target has been revised to $15. Analysts at Rodman & Renshaw started covering the stock with ‘”a Buy”‘ outlook in a report released in late August. As of March 07, 2024, The Benchmark Company has increased its “Hold” rating to a “Buy” for EBS.
Analyzing EBS Stock Performance
On last trading session, Emergent Biosolutions Inc [NYSE: EBS] plunged -4.53% to $10.32. The stock’s lowest price that day was $10.21, but it reached a high of $11.0 in the same session. During the last five days, there has been a surge of approximately 0.49%. Over the course of the year, Emergent Biosolutions Inc shares have dropped approximately -13.78%. Shares of the company reached a 52-week high of $13.41 on 10/30/25 and a 52-week low of $4.02 on 04/09/25.
Support And Resistance Levels for Emergent Biosolutions Inc (EBS)
According to the 24-hour chart, there is a support level at 10.02, which, if violated, would cause prices to drop to 9.72. In the upper region, resistance lies at 10.81. The next price resistance is at 11.30. RSI (Relative Strength Index) is 51.94 on the 14-day chart, showing neutral technical sentiment.
Is Emergent Biosolutions Inc subject to short interest?
Stocks of Emergent Biosolutions Inc saw a sharp steep in short interest on 2025-10-31 dropping by -1.39 million shares to 8.22 million. Data from Yahoo Finance shows that the short interest on 2025-09-30 was 9.61 million shares. A decline of -16.86% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 6.72 of the overall float, the days-to-cover ratio (short ratio) decline to 6.72.
Which companies own the most shares of Emergent Biosolutions Inc (EBS)?
In terms of Emergent Biosolutions Inc share price expectations, FactSet research, analysts set an average price target of 51.5 in the next 12 months, up nearly 376.41% from the previous closing price of $10.81. Analysts anticipate Emergent Biosolutions Inc stock to reach 65 by 2025, with the lowest price target being 38. In spite of this, 2 analysts ranked Emergent Biosolutions Inc stock as Buy at the end of 2025.
